Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-26

Clinical Trial Update: Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence [Phase 2]

View source ↗

Summary

This update reports completion of a Phase 2 trial evaluating Behavioral Naltrexone Therapy as a treatment for heroin dependence (opioid use disorder).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opiate Dependence | Phase 2 | Status: COMPLETED